- Home
- About Us
- Products
- Our Capabilities
- Services
- Contract Development and Manufacturing Organisation {CDMO)
- Contract Manufacturing (CMO]
- Contract Research (CRO)
- Custom Synthesis / Third— Party Manufacturing
- DMF Preparation
- Formulation Research & Development (FR&D)
- Global Marketing Representation
- Market Research & Business Intelligence
- Quality Control (QC) Auditing
- Strategic Marketing
- Supply Chain Management
- Technology Transfer & Scale Up
- Business Partners
- Contact Us
Suvorexant
CAS NO : 1030377-33-3
THERAPEUTIC CATEGORY : Insomnia
Synephrine Hydrochloride
CAS NO : 5985-28-4
THERAPEUTIC CATEGORY : Sympathomimetic Agent / Anti-Hypertensive
T-Butyl Chloro Acetate
CAS NO : 107-59-5
T-butyl-4-(2-chloropyrimidin-5-yloxy)butyrate
API : Obicetrapib
CAS NO : 945771-55-1
T4-Formic Acid-N-Methylamide
API : Levothyroxine
CAS NO : 2088032-78-2
IMPURUTY NAME : Levothyroxine T4-formic Acid-N-methylamide
Tacrolimus
CAS NO : 104987-11-3
THERAPEUTIC CATEGORY : Immunosuppressants
Tadalafil 10 / 20 Mg
CATEGORY : Urology
Tadalafil Citrate
CAS NO : 171596-29-5
THERAPEUTIC CATEGORY : Erectile Dysfunction/Sex Stimulants
Tamoxifen Citrate
CAS NO : 54965-24-1
THERAPEUTIC CATEGORY : Anti Cancer
Tamsulosin
CAS NO : 106133-20-4
THERAPEUTIC CATEGORY : Benign Prostatic
Tamsulosin (SR) + Dutasteride (IR)
USAGE : Combination Pellets
TYPE : Sustained Release /Controlled Release /Timed Release Pellets
Tamsulosin & Dutasteride
USAGE : Benign Prostatic Hyperplacia
TYPE : Sustained Release /Controlled Release /Timed Release Pellets
Tamsulosin Hcl
CAS NO : 106463-17-6
THERAPEUTIC CATEGORY : Benign Prostatic Hypertrophy/Treatment Of BPH
Tamsulosin HCl 0.4 Mg CR
CATEGORY : Urology
Tamsulosine Hydrochloride Pellets
USAGE : Benign Prostatic Hyperplasia
TYPE : Sustained Release /Controlled Release /Timed Release Pellets
Tapentadol
CAS NO : 175591-23-8
THERAPEUTIC CATEGORY : Pain Management/Analgesic